Clinical trials
Phase 2 Immunoblastic Lymphadenopathy trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Research UK | 1 |
| Herbert Irving Comprehensive Cancer Center | 1 |
| Institut Paoli-Calmettes | 1 |
| Peking Union Medical College Hospital | 1 |
| Qingdao University | 1 |
| Royal Marsden NHS Foundation Trust | 1 |
| Ruijin Hospital | 1 |
| Shandong Provincial Hospital | 1 |
| Sun Yat-sen University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunoblastic Lymphadenopathy | 9 |
| Lymphoma | 3 |
| Lymphoma, Large-Cell, Anaplastic | 3 |
| Burkitt Lymphoma | 2 |
| Congenital Abnormalities | 2 |
| Enteropathy-Associated T-Cell Lymphoma | 2 |
| Hodgkin Disease | 2 |
| Leukemia | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Leukemia, Myeloid, Accelerated Phase | 2 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.